Recurrent Chemotherapy Treated Indeterminate Dendritic Cell Tumor: Case Report and Literature Review

References

• Wood GS, Hu CH, Beckstead JH, Turner RR, Winkelmann RK. The indeterminate cell proliferative disorder: report of a case manifesting as an unusual cutaneous histiocytosis. J Dermatol Surg Oncol. 1985;11(11):1111–1119. doi:10.1111/j.1524-4725.1985.tb01399.x
   PubMedGoogle Scholar
• Emile JF, Abla O, Fraitag S, et al. Revised classification of histiocytoses and neoplasms of the macrophage-dendritic cell lineages. Blood. 2016;127(22):2672–2681. doi:10.1182/blood-2016-01-690636
   PubMed Web of Science ®Google Scholar
• Khoury JD, Solary E, Abla O, et al. The 5th edition of the World Health Organization classification of haematolymphoid tumours: myeloid and histiocytic/dendritic neoplasms. Leukemia. 2022;36(7):1703–1719. doi:10.1038/s41375-022-01613-1
   PubMed Web of Science ®Google Scholar
• Campo E, Jaffe ES, Cook JR, et al. The international consensus classification of mature lymphoid neoplasms: a report from the clinical advisory committee. Blood. 2022;140(11):1229–1253. doi:10.1182/blood.2022015851
   PubMed Web of Science ®Google Scholar
• Fournier J, Ingraffea A, Pedvis-Leftick A. Successful treatment of indeterminate cell histiocytosis with low-dose methotrexate*. J Dermatol. 2011;38(9):937–939. doi:10.1111/j.1346-8138.2010.01148.x
   PubMed Web of Science ®Google Scholar
• Kong FW, Read J, Pitney L, Tang F, Davidson S, Wheller L. S100‐negative indeterminate cell histiocytosis: in an eight‐month‐old boy. Australas J Dermatol. 2020;62(1):e124–e127. doi:10.1111/ajd.13390
   PubMed Web of Science ®Google Scholar
• Brown RA, Kwong BY, McCalmont TH, et al. ETV3-NCOA2 in indeterminate cell histiocytosis: clonal translocation supports sui generis. Blood. 2015;126(20):2344–2345. doi:10.1182/blood-2015-07-655530
   PubMed Web of Science ®Google Scholar
• Davick JJ, Kim J, Wick MR, Gru AA. Indeterminate dendritic cell tumor: a report of two new cases lacking the ETV3-NCOA2 translocation and a literature review. Am J Dermatopathol. 2018;40(10):736–748. doi:10.1097/DAD.0000000000001191
   PubMed Web of Science ®Google Scholar
• Thurner L, Bewarder M, Rosar F, et al. Indeterminate dendritic cell tumor with persistent complete metabolic response to BRAF/MEK inhibition. HemaSphere. 2021;Vol. 5(1). doi:10.1097/hs9.0000000000000511
   Web of Science ®Google Scholar
• Loghavi S, Curry JL, Garcia-Manero G, et al. Chronic myelomonocytic leukemia masquerading as cutaneous indeterminate dendritic cell tumor: expanding the spectrum of skin lesions in chronic myelomonocytic leukemia. J Cutan Pathol. 2017;44(12):1075–1079. doi:10.1111/cup.13039
   PubMed Web of Science ®Google Scholar
• Vener C, Soligo D, Berti E, et al. Indeterminate cell histiocytosis in association with later occurrence of acute myeloblastic leukaemia. Br J Dermatol. 2007;156(6):1357–1361. doi:10.1111/j.1365-2133.2007.07880.x
   PubMed Web of Science ®Google Scholar
• Xia DM, Zhou QT, Wang L. Typical leonine facies in a patient with indeterminate dendritic cell tumor. Int J Dermatol. 2022;62(1):128–129. doi:10.1111/ijd.16106
   PubMed Web of Science ®Google Scholar
• Lie E, Jedrych J, Sweren R, Kerns ML. Generalized indeterminate cell histiocytosis successfully treated with methotrexate. JAAD Case Rep. 2022;25:93–96. doi:10.1016/j.jdcr.2022.05.027
   PubMedGoogle Scholar
• Belina ME, Kwock JT, Al-Rohil R, Fresco A. An atypical myelomonocytic cell infiltrate: use of next-generation sequencing to diagnose indeterminate cell histiocytosis. Am J Dermatopathol. 2022;44(7):529–531. doi:10.1097/dad.0000000000002167
   PubMed Web of Science ®Google Scholar
• Fischer AS, Zaladonis AG, Subrt P, Tschen J, Hsu S. Indeterminate cell histiocytosis mimicking rosacea. Cureus. 2021;13(1):e12850. doi:10.7759/cureus.12850
   PubMed Web of Science ®Google Scholar
• Zhou N, Ge Y, Fang K, et al. BRAF wild-type recurrent indeterminate dendritic cell tumour presenting with leonine facies. J Eur Acad Dermatol Venereol. 2020;34(5):e230–e31. doi:10.1111/jdv.16172
   PubMed Web of Science ®Google Scholar
• Chen C, Nguyen GH, Zeng YP. Indeterminate cell histiocytosis presenting with leonine facies. Acta Derm Venereol. 2018;98(4):463–464. doi:10.2340/00015555-2866
   PubMed Web of Science ®Google Scholar
• Xu XL, Bu WB, Zong WK, Sun JF. Indeterminate cell histiocytosis: a case series and review of the literature. Eur J Dermatol. 2017;27(5):559–561. doi:10.1684/ejd.2017.3121
   PubMed Web of Science ®Google Scholar
• Horna P, Shao H, Idrees A, Glass LF, Torres-Cabala CA. Indeterminate dendritic cell neoplasm of the skin: a 2-case report and review of the literature. J Cutan Pathol. 2017;44(11):958–963. doi:10.1111/cup.13017
   PubMed Web of Science ®Google Scholar
• Tóth B, Katona M, Hársing J, Szepesi A, Kárpáti S. Indeterminate cell histiocytosis in a pediatric patient: successful treatment with thalidomide. Pathol Oncol Res. 2012;18(2):535–538. doi:10.1007/s12253-011-9405-8
   PubMed Web of Science ®Google Scholar
• Bettington A, Lai JK, Kennedy C. Indeterminate dendritic cell tumour presenting in a patient with follicular lymphoma. Pathology. 2011;43(4):372–375. doi:10.1097/PAT.0b013e32834685b7
   PubMed Web of Science ®Google Scholar
• Yin R, Zheng WJ, Yang XC, Hao F. Recurrent generalized indeterminate cell histiocytosis: a case report. J Am Acad Dermatol. 2010;63(1):e3–5. doi:10.1016/j.jaad.2009.10.010
   PubMedGoogle Scholar
• Ventura F, Pereira T, da Luz Duarte M, Marques H, Pardal F, Brito C. Indeterminate cell histiocytosis in association with acute myeloid leukemia. Dermatol Res Pract. 2010;2010:569345. doi:10.1155/2010/569345
   PubMedGoogle Scholar
• Cheuk W, Cheung FY, Lee KC, Chan JK. Cutaneous indeterminate dendritic cell tumor with a protracted relapsing clinical course. Am J Surg Pathol. 2009;33(8):1261–1263. doi:10.1097/PAS.0b013e3181a0cd38
   PubMed Web of Science ®Google Scholar
• Caputo R, Marzano AV, Passoni E, Bellinvia M. Chemotherapeutic experience in indeterminate cell histiocytosis. Br J Dermatol. 2005;153(1):206–207. doi:10.1111/j.1365-2133.2005.06644.x
   PubMed Web of Science ®Google Scholar
• Kolde G, Brocker EB. Multiple skin tumors of indeterminate cells in an adult. J Am Acad Dermatol. 1986;15(4 Pt 1):591–597. doi:10.1016/s0190-9622(86)70209-0
   PubMed Web of Science ®Google Scholar
• Segal GH, Mesa MV, Fishleder AJ, et al. Precursor Langerhans cell histiocytosis. An unusual histiocytic proliferation in a patient with persistent non-Hodgkin lymphoma and terminal acute monocytic leukemia. Cancer. 1992;70(2):547–553. doi:10.1002/1097-0142(19920715)70:2<547::aid-cncr2820700227>3.0.co;2-z
   PubMed Web of Science ®Google Scholar
• Flores‐Stadler EM, Gonzalez‐Crussi F, Greene M, Thangavelu M, Kletzel M, Chou PM. Indeterminate‐cell histiocytosis: immunophenotypic and cytogenetic findings in an infant. Med Pediatr Oncol. 1999;32(4):250–254. doi:10.1002/(sici)1096-911x(199904)32:4<250::Aid-mpo2>3.0.Co;2-#
   PubMedGoogle Scholar
• Rodriguez-Jurado R, Vidaurri-de la Cruz H, Duran-Mckinster C, Ruiz-Maldonado R. Indeterminate cell histiocytosis. clinical and pathologic study in a pediatric patient. Arch Pathol Lab Med. 2003;127(6):748–751. doi:10.5858/2003-127-748-ICH
   PubMed Web of Science ®Google Scholar
• Ozono S, Inada H, Nakagawa SI, et al. Juvenile myelomonocytic leukemia characterized by cutaneous lesion containing Langerhans cell histiocytosis-like cells. Int J Hematol. 2011;93(3):389–393. doi:10.1007/s12185-011-0787-x
   PubMed Web of Science ®Google Scholar